Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

Ater litigation was settled or tossed out last year, three others are still making their way through local, state and federal ...

Each monthly installment examines an individual aspect of these crucial conversations, including building trust, responding ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

Continued issues with implementation of the electronic medical certification system prompted yet another waiver extension ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye-called the ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Influenza — which is a "potentially lethal disease" according to experts — is even more dangerous in congregate settings.

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in patients with advanced ...

DEI is the common denominator between the $9 to $10 billion, and climbing, fraud among the Somali community in Minnesota.

Weather Channel meteorologist Kelly Cass joins "CBS News Mornings" with the latest on the forecast. "President Trump sets the terms. And ultimately, he'll decide what the iterations are of that," ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...